Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Scientists hunt for genetic clues in bladder cancer

NCT ID NCT02379429

First seen Nov 21, 2025 · Last updated Jun 19, 2026 · Updated 23 times

Summary

This study collects blood, urine, saliva, and tissue samples from 500 adults with or at risk for urothelial cancer (bladder, ureter, urethra). Researchers will analyze DNA and other molecular changes to understand how the cancer forms and progresses. Participants provide samples during standard care and are followed every 6 months for updates.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • National Institutes of Health Clinical Center

    RECRUITING

    Bethesda, Maryland, 20892, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this research could reveal genetic changes that lead to new treatments for bladder and urinary tract cancers.

What could go wrong

This is an observational study, not a treatment trial. It collects samples for future research, so there is no direct benefit to participants and no guarantee of new therapies.

Conditions

The condition(s) this trial relates to.

benign urinary system neoplasm malignant urinary system neoplasm urinary bladder cancer urinary bladder carcinoma Urinary Bladder Neoplasms urothelial carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.